Clinical Interests

Child and adolescent forensic psychiatry

Research Interests

Child and adolescent forensic psychiatry; prevention of violence in youth; neuroimaging in children and adolescents; genetics; pediatric clinical trials

MD: Buffalo, School of Medicine, State University of New York, 1997.

Residency: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, 1997-2001.

Fellowship: Forensic Fellow, Department of Psychiatry, University of Cincinnati, Cincinnati, OH, 2001-2002.

Fellowship: Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, 2002-2004.

Licensure: State of Ohio Medical License, 2001.

Certifications: Psychiatry (2002), Forensic Psychiatry (2003), Child and Adolescent Psychiatry (2004); Dr. Barzman successfully passed the Maintenance of Certification Examination in Psychiatry, Forensic Psychiatry, and Child and Adolescent Psychiatry in April 2011. 

Recertification: Passed Modular Examination for Maintenance of Certification in the Specialty of Psychiatry and the Subspecialties of Forensic Psychiatry and Child and Adolescent Psychiatry in April 2011.

Barzman D, Mossman D, Appel K, Blom T, Strawn J, Ekhator N, Patel B, DelBello M, Sorter M, Klein D, Geracioti T. The Association Between Salivary Hormone Levels and Children’s Inpatient Aggression: A Pilot Study. Psychiatric Quarterly. Epub ahead of print. 2013.

Barzman D, Mossman D, Sonnier L, Sorter M. Brief Rating of Aggression by Children and Adolescents (BRACHA): A Reliability Study. Journal of the American Academy of Psychiatry and the Law. 2012;40(3):374-382.

Barzman D, Brackenbury L, Sonnier L, Schnell B, Cassedy A, Salisbury S, Sorter M, Mossman D. Brief Rating of Aggression by Children and Adolescents (BRACHA): Development of a Tool to Assess Risk of Inpatients’ Aggressive Behavior. Journal of the American Academy of Psychiatry and the Law. 2011;39(2):170-179.

Barzman D, Patel A, Sonnier L, Strawn J. Neuroendocrine Aspects of Pediatric Aggression: Can Hormone Measures Be Clinically Useful? Neuropsychiatric Disease and Treatment. 2010;6:691-697.

Brackenbury L, Barzman D, Dunseith Neal. Evaluating Forensic Interviewing of Children in Sexual Abuse Cases: Guidelines for the Forensic Psychiatrist. American Journal of Forensic Psychiatry. 2009;30 (2).

Barzman DH, Findling RL. Pharmacological treatment of pathologic aggression in children. Int Rev Psychiatry. 2008 Apr;20(2):151-7. 

Barzman DH, Delbello MP, Fleck DE, Lehmkuhl H, Strakowski SM. Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder. Bipolar Disorders. 2007;9(4):339-44.

Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM. The Efficacy and Tolerability of Quetiapine versus Divalproex for the Treatment of Impulsivity and Reactive Aggression in Adolescents with Co-occurring Bipolar Disorder and Disruptive Behavior Disorder(s). The Journal of Child and Adolescent Psychopharmacology. 2006;16(6):665-70.

DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA., Barzman DH, Nelson E, Strakowski SM. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:305-313.

Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Pamela Campbell, Strakowski SM. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. The Journal of Child and Adolescent Psychopharmacology. 2004;14:593-600.

Clinical Interests

Outpatient treatment of children and adolescents; ADHD; anxiety disorders; mood disorders; pediatric psychopharmacology and international adoption

MD: University of Kentucky, Lexington, KY, 2002.

Residency: Psychiatry, University of Cincinnati/University Hospital, Cincinnati, OH.

Fellowship: Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Certification: Psychiatry, 2007.

Pediatric mood disorders

BS: Cornell University, Ithaca, New York 1995.

MD: University of Rochester School of Medicine, Rochester, New York 2002.

MS: University of Cincinnati, Department of Environmental Health, Cincinnati, Ohio, anticipated 2005.

Internship and Residencies: 1995-1996 Resident in Psychiatry, Payne Whitney Clinic New York Hospital, Cornell Medical Center, New York, New York, 1996-1998 Resident in Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Fellowships: 1990 National Science Foundation Young Scientist Training Program, 1991-1993 Fellow, MD/PhD Program, University of Rochester School of Medicine, 1998-2000 Clinical Fellow, Child and Adolescent Psychiatry, Children's Hospital Medical Center, Cincinnati, Ohio,1998-2000 Research Fellow, Bipolar and Psychotic Disorders Research Program, Department of Psychiatry, University of Cincinnati College of Medicine.

Certification: Psychiatry, 1998.

MD: Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 1981.

Residency: Karl Menninger School of Psychiatry, Topeka, KS.

Fellowship: Child and Adolescent Psychiatry, Karl Menninger School of Psychiatry, Topeka, KS.

Certifications: Psychiatry, 1988; Child and Adolescent Psychiatry, 1990; Psychoanalysis, 1994; Child and Adolescent Psychoanalysis, 1994.

Delgado SV, Strawn J. Termination of psychodynamic psychotherapy with adolescents: a review and contemporary perspective. Bulletin of the Menninger Clinic. 2012;76(1):21-52.

Delgado SV, Wassenaar E, Strawn J. Psychiatric disorder or nonverbal learning disorder? Current Psychiatry. 2011;10(5):17-34.

Kowatch RA, Monroe E, Delgado SV. Not all mood swings are bipolar disorder. Current Psychiatry. 2011;10(2):39-52.

Harris E, Eng HY, Kowatch R, Delgado SV, Saldana SN. Disinhibition as a Side Effect of Treatment with Fluvoxamine in Pediatric Patients with Obsessive Compulsive Disorder. J Child Adolesc Psychopharmacol. 2010.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord. 2009;11:483–493.

Delgado, SV. Psychotherapy Rounds. Psychodynamic Psychotherapy for Children and Adolescents: An Old Friend Revisited. Psychiatry. 2008;5(5):67-72.

Fragile X syndrome; autism spectrum disorders

MD: University of Cincinnati

Residency: Psychiatry, Indiana University; Child and Adolescent Psychiatry, Indiana University.

Erickson CA, Mullett JE, McDougle CJ. Brief Report: Acamprosate in fragile X syndrome. J Autism Dev Disorder, 2010 Mar 6.

Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treat Options Neurology. 12: 529-538, 2010.

Stigler KA, Erickson CA, Mullett JE, Posey DJ, McDougle CJ. Paliperidone for irritability in autistic disorder. J Child Adolesc Psychopharmacol.  Feb;20(1):75-8, 2010.

Wink LK, Erickson CA, Chambers JE, McDougle CJ. Comorbid intellectual disability and borderline personality disorder: A case series. Psychiatry. 73(3): 279-289, 2010.

Erickson CA, Stigler KA, Wink LK, Weng N, Weiler IJ, Greenough WT, McDougle CJ. Riluzole in Fragile X Syndrome, Brain Research, 1380: 264-70, 2011.

Erickson CA, Early M, Wink LK, McDougle CJ. An open-label naturalistic pilot study of acamprosate in youth with autistic disorder, Journal of Child Adolesc Psychopharmacology, 2012.

Wink LK, Erickson CA, Stigler KA, McDougle CJ. Riluzole in autistic disorder, Journal of Child and Adolescent Psychopharmacology. 2012.

Erickson CA, Stigler KA, Wink LK, Mullett JE, Kohn A, Posey DJ, McDougle CJ. A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology. 2011 Feb 12.

Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone palmitate in a child with autistic disorder. J Child Adolesc Psychopharmacology. 2012.

Anxiety disorders; Obsessive Compulsive Disorder, Tourette Syndrome

Cognitive neuroscience; neurophysiology as a tool to improve our understanding of the etiology and pathophysiology of mental illness; improving treatment of anxiety disorders and Tourette Syndrome using cognitive behavior therapy, biofeedback and habit reversal therapy

Harris, E., Witter, M. P., Weinstein, G., and Stewart, M. Intrinsic connectivity of the rat subiculum. I. Dendritic morphology and patterns of axonal arborization by pyramidal neurons. J. Comp. Neurol., 2001; 436:490-505.

Harris, E. and Stewart, M. Intrinsic connectivity of the rat subiculum. II. Properties of synchronous spontaneous activity and a demonstration of multiple generator regions. J. Comp. Neurol., 2001; 436:506-518.

Harris, E. and Stewart, M. Propagation of synchronous epileptiform events from subiculum backward into area CA1 of rat brain slices. Brain Res., 2001, 895: 41-49.

Presentations, Most Recent

Harris, E. Brain structures underlying fear. Presented to the Child Psychiatry Residency Training Program at CCHMC. February 2, 2008; Cincinnati, OH.

Harris, E.; Gilbert, D. The premotor potential in simple vs. complex motor tics. Presented at the MEG Users' Meeting. November 8, 2007; Cincinnati, OH.

Consultation-liaison psychiatry; psychiatry with medical comorbidity

MD: The Ohio State University, Columbus, OH, 2004.

Internship: Pediatrics, Children’s National Medical Center, Washington, DC, 2005.

Residency: Psychiatry, The Cambridge Hospital, Cambridge, MA, 2008.

Fellowship: Child and Adolescent Psychiatry, Massachusetts General Hospital/McLean Hospital, Boston, MA, 2010. 

Certification: Psychiatry, 2008; Child and Adolescent Psychiatry, 2010.

Kurtz BP, Abrams AN. Psychiatric aspects of pediatric oncology. Pediatr Clin N Am. 2011 Aug;58(4):1003-1023.

Kurtz BP, Abrams AN. Psychiatric aspects of pediatric oncology. Child Adolesc Psychiatr Clin N Am. 2010 Apr;19(2):401-421.

Eating disorders; body image; mood disorders

Inpatient and outpatient child psychiatry diagnosis, treatment and research; bipolar and mood disorders; attention deficit hyperactivity disorder; childhood trauma; behavioral disorders 

Resident education; inpatient adolescent psychiatry; community mental health

MD: University of the East Ramon Magsaysay Memorial Medical Center, Philippines, 1997.

Residency: General Psychiatry, University of Cincinnati, Cincinnati, OH, 2002.

Fellowship: Child & Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2003.

Certification: Diplomate, Psychiatry, American Board of Psychiatry and Neurology, 2003; Child and Adolescent Psychiatry, 2004.

MD: University of Cincinnati, Cincinnati, Ohio, 1985.

Residency: Psychiatry / Child Psychiatry, University of Cincinnati, Cincinnati, Ohio.

Certification: Psychiatry, 1992; Child Psychiatry, 1993.

MD: University of Cincinnati, Cincinnati, OH, 2005.

Residency: University of Cincinnati, Cincinnati, OH. 

Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH. 

Certification: Diplomate, American Board of Psychiatry and Neurology – General Psychiatry; American Board of Psychiatry and Neurology – Child & Adolescent Psychiatry.

Clinical Interests

Infant psychiatry

Research Interests

Transgenerational trauma; attachment disorders 

MD: Saint Louis University, Saint Louis, MO, 1999.

Residency: Pediatrics, Child & Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center / University of Cincinnati, Cincinnati, OH.

Autism spectrum disorders; Angelman syndrome

MD: Indiana University School of Medicine, Indianapolis, IN.

Residency: Psychiatry, Indiana University School of Medicine, Indianapolis, IN.

Fellowship: Child Psychiatry, Indiana University School of Medicine, Indianapolis, IN.

Fellowship: Autism and Developmental Disabilities, Indiana University School of Medicine, Indianapolis, IN.

Erickson CA, Wink LK, Schaefer TL, Shaffer RC. Medication Management of Fragile X Syndrome. In The Comprehensive Guide to Autism, Patel VP, Preedy VR, Martin CR (eds), Springer Reference, Heidelberg, Germany. 2013. 

Wink LK, Erickson CA, McDougle CJ, Stigler KA. Pharmacotherapy of autism spectrum disorders. In The Handbook of Autism: A Concise Guide, Treadwell-Deering D, Kober D (eds), World Scientific, Inc., New Jersey, 2013.

Erickson CA, Early M, Stigler KA, Wink LK, Mullett JE, McDougle CJ. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. J Child Adolesc Psychopharmacol. 2011 Dec 2.

Wink LK, Erickson CA, Stigler, KA, McDougle CJ. Riluzole in autistic disorder. J Child Adolesc Psychopharmacology. 2011;21(4):375-379. 

Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone Palmitate in a Child with Autistic Disorder. J Child Adolesc Psychopharmacology. 2011 Oct;21(5):491-3. 

Orsagh-Yentis DK, Wink LK, Erickson CA, Stigler KA, McDougle CJ. Buspirone for Bruxism in a Child with Pervasive Developmental Disorder-Not Otherwise Specified. J Child Adolesc Psychopharmacol. 2011 Dec. 

Erickson CA, Early M, Stigler KA, Wink LK, Mullett JE, McDougle CJ. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. J Child Adolesc Psychopharmacol. 2011 Dec. 

Wink LK, Plawecki MH, Erickson CA, Stigler KA, McDougle CJ. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs. 2010 May.

Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treat Options Neurology. 2010;12: 529-538.

Wink LK, Erickson CA, Chambers JE, McDougle CJ: Comorbid intellectual disability and borderline personality disorder: A case series. Psychiatry. 2010;73(3):279-289.